Inside the research
Ecolab Inc.
ECL Research profile · latest available data
Price overview
$279.49
▲ +4.12 (+1.5%)
| 52w hi | $305.88 |
|---|---|
| 52w lo | $244.41 |
| Vol | 1.01M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.26
| Short | -0.16 |
|---|---|
| Medium | -0.33 |
| Long | -0.34 |
computed 2026-09-27
Key fundamentals
Ecolab Inc.
Basic Materials · Specialty Chemicals
| Market cap | $78.35B |
|---|---|
| Enterprise value | $87.16B |
| Trailing P/E | 37.47x |
| Forward P/E | 29.68x |
| EV / EBITDA | 21.07x |
| P / S (ttm) | 4.65x |
| Profit margin | 12.6% |
| Return on equity | 22.0% |
| Revenue growth | +9.7% |
| Earnings growth | +3.3% |
| Debt / equity | 138.02 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.14 | |
| Sector | -0.02 | |
| Technical | -0.18 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Risk Metrics
| Beta vs SPX | 0.56 |
|---|---|
| Corr SPX | 0.44 |
| Annual vol | 20.7% |
| Annual ret | +7.4% |
| Sharpe | 0.36 |
| Max DD | -20.3% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $317.48 |
|---|---|
| High / Low | $352.00 / $270.00 |
| Median | $325.00 |
| Analysts | 21 |
| Strong Buy | 6 | |
|---|---|---|
| Buy | 13 | |
| Hold | 8 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-04-30 | Citigroup | → Buy |
| 2026-04-21 | B of A Securities | → Buy |
| 2026-04-13 | Citigroup | → Buy |
| 2026-04-09 | UBS | → Neutral |
| 2026-03-24 | JP Morgan | → Overweight |
| 2026-03-24 | Baird | → Outperform |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-28 | Earnings Release, Exhibits | read |
| 2026-05-29 | Other Material Event, Exhibits | read |
| 2026-05-11 | Officer / Director Change, Shareholder Vote | read |
| 2026-04-28 | Earnings Release, Exhibits | read |
| 2026-04-15 | Material Agreement, Material Obligation… | read |
| 2026-03-27 | Earnings Release, Exhibits | read |
| 2026-03-20 | Earnings Release, Exhibits | read |
| 2026-02-25 | Officer / Director Change, Exhibits | read |
| 2026-02-23 | Officer / Director Change | read |
| 2026-02-10 | Earnings Release, Restructuring… | read |
| 2025-10-28 | Earnings Release, Exhibits | read |
| 2025-08-27 | Other Material Event, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | LARSON MICHAEL | Director | Grant | 130 | — |
| 2026-06-30 | Vautrinot Suzanne M | Director | Grant | 130 | — |
| 2026-06-30 | NOWELL LIONEL L III | Director | Grant | 130 | — |
| 2026-06-30 | MacLennan David | Director | Grant | 46 | $12.81K |
| 2026-06-30 | MacLennan David | Director | Grant | 130 | — |
| 2026-06-30 | McKibben Tracy B | Director | Grant | 130 | — |
| 2026-06-30 | Whalen Julie | Director | Grant | 130 | — |
| 2026-06-30 | ZILLMER JOHN J | Director | Grant | 130 | — |
| 2026-05-04 | MacLennan David | Director | Buy | 800 | $205.53K |
| 2026-05-04 | Cook Gregory B | Officer, Co-COO - Global | Option exercise | 8.40K | — |
Flow & Concentration
| Insider 180d net | $205.53K |
|---|---|
| Insider buys / sells | 1 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 98.5% |
| HHI | 5,511 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $3.29B | 11.77M |
| Fidelity / FMR LLC | $425.24M | 1.53M |
| Citadel Advisors | $338.65M | 1.22M |
| Capital Research / Capital World | $273.94M | 983.24K |
| AQR Capital Management | $116.16M | 418.37K |
| Millennium Management | $65.45M | 234.91K |
| T. Rowe Price Group | $125.94K | 452.04K |
As of 2026-06-30
Connections
Customers: U.S. Gulf Co, 8030.SR
Dividends
| Yield (TTM) | 0.52% |
|---|---|
| $ / share (TTM) | $1.46 |
| 5y CAGR | +7.2% |
Annual dividend per share
| 2021 | $1.95 |
|---|---|
| 2022 | $2.06 |
| 2023 | $2.16 |
| 2024 | $2.36 |
| 2025 | $2.68 |
| 2026 | $0.73 |
Federal Contracts
| Amount | Agency | Description |
|---|---|---|
| $5.35M | Department of Veterans Affairs | WATER TREATMENT AND MONITORING SERVICES |
| $1.44M | Department of Justice | WATER CHEMICAL TREATMENT SERVICES |
| $1.35M | Department of Defense | THIS REQUIREMENT IS A MULTIYEAR CONTRACT FOR BOILER CHEMICALS IN SUPPORT OF THE |
| $1.32M | Social Security Administration | WATER TREATMENT AND CHEMICAL SERVICES FOR SSA HEADQUARTERS BUILDINGS AND THE PER |
| $1.21M | Department of Defense | FY23 TASK ORDER FOR WASTE WATER CHEMICAL TREATMENT FOR ALL NAVFAC |
| $1.16M | Department of Defense | THERMAL COMODITY CHEMICALS |
| $1.05M | Department of Defense | TASK ORDER FOR WATER CHEM TREATMENT - 2ND BRIDGE FUNDING TASK ORD |
| $800.00K | Department of Defense | 8-MONTH EXTENSION |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $16.08B | +6.2% | |
| Operating income | $2.80B | +8.9% | |
| Net income | $2.08B | +48.5% | |
| Cash from ops | $2.81B | +15.0% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $276.36 | $280.66 | $273.14 | $279.49 | 1.01M |
| Sep 24 | $276.07 | $278.14 | $273.75 | $275.37 | 976.10K |
| Sep 23 | $275.39 | $277.81 | $273.66 | $276.72 | 1.06M |
| Sep 22 | $272.84 | $277.11 | $271.00 | $276.22 | 1.20M |
| Sep 21 | $272.10 | $272.11 | $267.83 | $269.98 | 803.70K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →